← All investors
Ridgeback Capital
11 portfolio companies · 2 on the map · $217.4M raised · 2 cities
Portfolio map
2 Ridgeback Capital portfolio companies on the map.
Portfolio companies
LENZ THERAPEUTICS
San Diego
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Pharmaceutical Manufacturing$217.4M
Butterfly Network
Burlington
Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Medical Equipment ManufacturingPublicEst. 2011
More portfolio companies
9 more Ridgeback Capital investments we track beyond the map.
Pyxis OncologyBoston · Post-IPO Equity
Quell TherapeuticsLondon · Series B
Caribou BiosciencesBerkeley · Series C
Reverie LabsCambridge · Series A
TwinStrand BiosciencesSeattle · Series B
AdaptimmuneOxford · Series A
ESSA PharmaVancouver · Post-IPO Equity
Bellicum PharmaceuticalsHouston · Series C
Viracta TherapeuticsCardiff By The Sea · Post-IPO Equity
Portfolio map
2 Ridgeback Capital portfolio companies on the map.